Roberto Bortolus

1.7k total citations
48 papers, 796 citations indexed

About

Roberto Bortolus is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Roberto Bortolus has authored 48 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Roberto Bortolus's work include Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Roberto Bortolus is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Roberto Bortolus collaborates with scholars based in Italy, Ukraine and Netherlands. Roberto Bortolus's co-authors include M. Trovò, A. Garbeglio, Annalisa Drigo, Eugenio Borsatti, Sandro Morassut, Tanja Baresic, M. Cimitan, Vincenzo Canzonieri, Mauro Arcicasa and Vittorina Zagonel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Molecular Sciences.

In The Last Decade

Roberto Bortolus

47 papers receiving 774 citations

Peers

Roberto Bortolus
N. Dupouy France
A. Muhs United States
Joanne Stetz United States
R.C. Nichols United States
Roberto Bortolus
Citations per year, relative to Roberto Bortolus Roberto Bortolus (= 1×) peers Patrizia Ciammella

Countries citing papers authored by Roberto Bortolus

Since Specialization
Citations

This map shows the geographic impact of Roberto Bortolus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Bortolus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Bortolus more than expected).

Fields of papers citing papers by Roberto Bortolus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Bortolus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Bortolus. The network helps show where Roberto Bortolus may publish in the future.

Co-authorship network of co-authors of Roberto Bortolus

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Bortolus. A scholar is included among the top collaborators of Roberto Bortolus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Bortolus. Roberto Bortolus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cannizzaro, Renato, S. Maiero, Sonia Facchin, et al.. (2025). Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study. Journal of Clinical Medicine. 14(13). 4783–4783. 1 indexed citations
3.
Napoli, Giuseppe, Stefano Arcangeli, Bruno Fionda, et al.. (2022). A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). Current Oncology Reports. 24(11). 1633–1644. 9 indexed citations
5.
Dreussi, Eva, Roberto Bortolus, Chiara Romualdi, et al.. (2019). rs4143815-PDL1, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy. International Journal of Molecular Sciences. 20(9). 2082–2082. 5 indexed citations
6.
Zattoni, Fabio, Alessandro Morlacco, Fabio Matrone, et al.. (2019). Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy. Minerva Urologica e Nefrologica. 71(5). 508–515. 5 indexed citations
7.
Baldari, Sergio, Giuseppe Boni, Roberto Bortolus, et al.. (2017). Management of metastatic castration-resistant prostate cancer: A focus on radium-223. Critical Reviews in Oncology/Hematology. 113. 43–51. 17 indexed citations
8.
Candido, Saverio, Matteo Di Maso, Diego Serraino, et al.. (2016). Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder. Tumor Biology. 37(7). 9855–9863. 17 indexed citations
10.
Giacalone, Annalisa, et al.. (2006). What elderly cancer patients want to know? Differences among elderly and young patients. Psycho-Oncology. 16(4). 365–370. 35 indexed citations
11.
Cimitan, M., Roberto Bortolus, Sandro Morassut, et al.. (2006). [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. European Journal of Nuclear Medicine and Molecular Imaging. 33(12). 1387–1398. 240 indexed citations
12.
Aleman, Berthe M.P., John Raemaekers, Margreet H.A. Baaijens, et al.. (2006). Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin’s lymphoma. International Journal of Radiation Oncology*Biology*Physics. 67(1). 19–30. 35 indexed citations
13.
Aleman, Berthe M.P., T. Girinsky, Richard W.M. van der Maazen, et al.. (2005). Quality control of involved-field radiotherapy in patients with advanced Hodgkin’s lymphoma (EORTC 20884). International Journal of Radiation Oncology*Biology*Physics. 63(4). 1184–1190. 18 indexed citations
14.
Mazzaro, Cesare, Vittorina Zagonel, S. Monfardini, et al.. (1996). Hepatitis C virus and non‐Hodgkin's lymphomas. British Journal of Haematology. 94(3). 544–550. 146 indexed citations
15.
Roncadin, Mario, Mauro Arcicasa, Vittorina Zagonel, et al.. (1994). Total body irradiation and prednimustine in chronic lymphocytic leukemia and low grade non-Hodgkin's lymphomas. A 9-year experience at a single institution. Cancer. 74(3). 978–984. 13 indexed citations
16.
Trovò, M., Emilio Minatel, Giovanni Franchin, et al.. (1992). Radiotherapy enhanced by cis-platinum in stage III non-small cell lung cancer: a phase II study. Radiotherapy and Oncology. 23(4). 241–244. 13 indexed citations
17.
Franchin, Giovanni, Salvatore Tumolo, Carlo Scarabelli, et al.. (1991). Whole abdomen radiation therapy after a short chemotherapy course and second-look laparotomy in advanced ovarian cancer. Gynecologic Oncology. 41(3). 206–211. 3 indexed citations
18.
Roncadin, Mario, Mauro Arcicasa, Roberto Bortolus, et al.. (1991). Feasibility of Total Body Irradiation in Chronic Lymphocytic Leukemia and Low-Grade Non-Hodgkin's Lymphomas. Cancer Investigation. 9(4). 403–407. 8 indexed citations
19.
Paoli, Antonino De, M. Trovò, Giovanni Franchin, et al.. (1988). Multiple fraction per day radiation therapy for inoperable esophageal cancer. International Journal of Radiation Oncology*Biology*Physics. 14(5). 855–860. 15 indexed citations
20.
Franchin, Giovanni, Emilio Minatel, Mario Roncadin, et al.. (1988). Accelerated split course regimen in the treatment of brain metastases. Radiotherapy and Oncology. 12(1). 39–44. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026